Novo says Ozempic starter kits still not available in Germany in Q2

Novo Nordisk has warned that starter kits of its popular diabetes drug Ozempic will continue to not be available in Germany during the second quarter, urging physicians to only issue prescriptions for patients already on the therapy.

In a statement by Novo posted on the website of German healthcare regulator BfArM, the Danish drugmaker also urged doctors again to only prescribe Ozempic for its approved use in diabetes, saying that there were sufficient supplies of Wegovy, the obesity drug that is based on the same active ingredient.

 

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)